Cargando…
Autosomal dominant polycystic kidney disease: recent advances in clinical management
The first clinical descriptions of autosomal dominant polycystic kidney disease (ADPKD) go back at least 500 years to the late 16 (th) century. Advances in understanding disease presentation and pathophysiology have mirrored the progress of clinical medicine in anatomy, pathology, physiology, cell b...
Autores principales: | Mao, Zhiguo, Chong, Jiehan, Ong, Albert C. M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
F1000Research
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4991528/ https://www.ncbi.nlm.nih.gov/pubmed/27594986 http://dx.doi.org/10.12688/f1000research.9045.1 |
Ejemplares similares
-
Recent advances in the clinical management of autosomal dominant polycystic kidney disease
por: Torra, Roser
Publicado: (2019) -
Drug repurposing in autosomal dominant polycystic kidney disease: back to the future with pioglitazone
por: Mao, Zhiguo, et al.
Publicado: (2021) -
Chromatin Methylation Abnormalities in Autosomal Dominant Polycystic Kidney Disease
por: Xu, Jing, et al.
Publicado: (2022) -
New onset diabetes after kidney transplantation in patients with autosomal dominant polycystic kidney disease: systematic review protocol
por: Yang, Bo, et al.
Publicado: (2015) -
The Controversial Role of Fibrosis in Autosomal Dominant Polycystic Kidney Disease
por: Fragiadaki, Maria, et al.
Publicado: (2020)